tiprankstipranks
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market
Want to see DE:6Y4 full AI Analyst Report?

Vicore Pharma Holding AB (6Y4) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Vicore Pharma Holding AB’s (6Y4) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Vicore Pharma Holding AB is a Sell.
Vicore Pharma Holding AB’s (6Y4) 20-Day exponential moving average is 0.88, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Buy.
Vicore Pharma Holding AB’s (6Y4) 50-Day exponential moving average is 0.90, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.

Vicore Pharma Holding AB (6Y4) Pivot Points

May 01, 2026, 02:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.90
0.90
0.90
0.90
0.90
0.90
0.90
Fibonacci
0.90
0.90
0.90
0.90
0.90
0.90
0.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vicore Pharma Holding AB (6Y4) Moving Averages

May 01, 2026, 02:22 PM
Period
Simple
Exponential
MA5
0.88Buy
0.89Buy
MA10
0.88Buy
0.88Buy
MA20
0.87Buy
0.88Buy
MA50
0.90Sell
0.90Sell
MA100
0.94Sell
0.92Sell
MA200
0.94Sell
0.89Sell
Vicore Pharma Holding AB’s (6Y4) 10-Day exponential moving average is 0.88, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Buy.
Vicore Pharma Holding AB’s (6Y4) 100-Day exponential moving average is 0.92, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 50-day simple moving average is 0.90, creating a Sell signal.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 100-day simple moving average is 0.94, creating a Sell signal.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 200-day simple moving average is 0.94, creating a Sell signal.

Vicore Pharma Holding AB (6Y4) Technical Indicators

May 01, 2026, 02:22 PM
Name
Value
Implied Action
RSI (14)
51.00
Neutral
STOCH (9,6)
91.40
Sell
STOCHRSI (14)
63.25
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
8.78
Buy
Williams %R
-19.35
Sell
CCI (14)
47.49
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
47.68
Neutral
ROC
-6.32
Sell
Vicore Pharma Holding AB’s (6Y4) Relative Strength Index (RSI) is 51.00, creating a Neutral signal.
Vicore Pharma Holding AB’s (6Y4) Trend Strength Indicator (ADX) is 8.78, creating a Buy signal.
Vicore Pharma Holding AB’s (6Y4) Commodity Channel Index (CCI) is 47.49, creating a Neutral signal.
Vicore Pharma Holding AB’s (6Y4) Price Rate of Change (ROC) is -6.32, creating a Sell signal.

FAQ

Is 6Y4 a Buy, Hold, or Sell?
Based on 6Y4’s technical indicators, 6Y4 is a Hold.
    What is 6Y4’s RSI (14)?
    6Y4’s RSI (14) is 51.00, which suggests 6Y4 is a Neutral.
      What is 6Y4’s MACD?
      6Y4’s MACD is >-0.01, which suggests 6Y4 is a Sell.
        What is 6Y4’s 5-day moving average?
        6Y4’s 5-day moving average is 0.88, which suggests 6Y4 is a Buy.
          What is 6Y4’s 20-day moving average?
          6Y4 20-day moving average is 0.87, which suggests 6Y4 is a Buy.
            What is 6Y4’s 50-day moving average?
            6Y4’s 50-day moving average is 0.90, which suggests 6Y4 is a Sell.
              What is 6Y4’s 200-day moving average?
              6Y4’s 200-day moving average is 0.94, which suggests 6Y4 is a Sell.
                What is 6Y4’s Williams % R (14)?
                6Y4’s Williams % R (14) is -19.35, which suggests 6Y4 is a Sell.
                  What is 6Y4’s CCI (14)?
                  6Y4’s CCI (14) is 47.49, which suggests 6Y4 is a Neutral.
                    What is the share price of Vicore Pharma Holding AB?